ISM-5939

N/A

Report date: 2024/11/22 17:27:53
NME

Base Information

Drug NameISM-5939
Drug Alias NameISM5939ISM-5939
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEctonucleotide Pyrophosphatase/Phosphodiesterase 1 inhibitors
TargetsEctonucleotide Pyrophosphatase/Phosphodiesterase 1
Therapy Area/IndicationsSolid tumoursHypophosphatasiaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesInsilico Medicine Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInsilico Medicine LtdInSilico Medicine Hong Kong Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursHypophosphatasiaNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A